healthy adult woman
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Japanese women aged 35 to 60 at the time of obtaining written consent 2) Those who have sexual intercourse more than twice a month 3) Subjects who have received a sufficient explanation of the purpose and content of the research, are capable of giving consent, have fully understood the study, voluntarily applied to participate in the study, and agreed to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1.Subjects with systolic blood pressure of 180 mmH or higher 2.Subjects who are likely to develop a serious allergy to food 3.Currently pregnant or breastfeeding. Or a person who may have such a possibility during the test period 4.Liver/kidney/cardiac disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, brain disease, malignant tumor, immune disease, serious disease such as heart disease, thyroid disease, other metabolic diseases Those who have a serious current disease such as disease or a history 5.Subjects who are currently undergoing drug treatment, outpatient treatment, diet therapy, or exercise therapy for any serious or chronic disease. 6.Subjects using health foods, supplements, and medicines that affect menopausal symptoms and sexual function 7.Subjects with current or past drug or alcohol dependence 8.Subjects who are undergoing hospital visits due to mental disorders (depression, etc.), sleep disorders, etc., or who have a history of mental disorders in the past 9.Subjects with irregular life rhythm due to night work or shift work 10.Subjects whose lifestyle habits may change during the test period (long-term travel, etc.) 11.Subjects with extremely irregular lifestyles such as eating and sleeping 12.Those who have an extremely unbalanced diet 13.Subjects who participated in other clinical trials (research) within 3 months prior to the date of consent acquisition, or those who plan to participate in other clinical trials (research) during the trial period 14.Subjects who have collected or donated more than 200 mL of blood within 1 month or 400 mL of blood within 3 months prior to the date of obtaining informed consent. 15.Subjects who have difficulty keeping track of various questionnaires 16.Subjects judged to be unsuitable as subjects based on the results of SCR 17.Others who are judged by the principal investigator to be unsuitable as subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.FSFI 2.Kupperman Women's Health Survey | — |
Countries
Japan
Contacts
BHN Co., Ltd Evidence-Based Functional Food Business Promotion Office